Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

ESC Congress Hot Lines target heart failure, prevention and coronary artery disease

0

Sophia Antipolis, 27 July 2016: The highly anticipated ESC Congress 2016 hot lines are set to reveal the latest discoveries in the fields of heart failure, cardiovascular disease (CVD) prevention, and coronary artery disease in six packed sessions.

Six Hot Lines sessions:

Innovative approaches for the treatment of heart failure (HF) will be presented in five trials:

  • DANISH: Effect of implantable cardioverter defibrillator on mortality in non-ischaemic systolic HF
  • REM-HF: Evaluation of implantable devices using remote monitoring
  • MORE-CARE: Impact of remotely monitoring biventricular defibrillators on outcomes and resources
  • CHART-1: Cardiopoietic regenerative therapy for congestive HF
  • Allogeneic mesenchymal stem cells for non-ischaemic cardiomyopathy

Preventive strategies will be unveiled in acute coronary syndromes (ACS), sleep apnoea, and hypertension:

  • NIPPON: Optimal dual antiplatelet treatment duration following bioabsorbable drug eluting stent
  • ANTARCTIC: Platelet function monitoring in elderly patients stented for ACS
  • SAVE: Results from the sleep apnoea cardiovascular endpoints study
  • NACIAM: Early N-acetylcysteine with glyceryl trinitrate in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
  • Median nerve modulation: A novel approach to resistant hypertension

Novel preventive treatments in lipids will be released:

  • HIJ-PROPER: LDL cholesterol targeting with pitavastatin plus ezetimibe
  • OPTICARE: Trial of educational and behavioural intervention for cardiac rehabilitation
  • Effect of long-term lower LDL cholesterol, lower systolic blood pressure, or both on risk of CVD
  • ESCAPE: Effect of alirocumab on frequency of lipoprotein apheresis
  • Apheresis as a novel treatment for refractory angina with raised lipoprotein(a)

The use of imaging in the diagnosis and management of coronary artery disease will be discussed:

  • CONSERVE: Direct versus selective catheterisation guided by coronary computed tomography (CT) in stable coronary artery disease
  • DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting?
  • CE-MARC 2: Diagnostic strategies in patients with suspected coronary heart disease
  • PACIFIC trial: Head-to-head comparison of coronary CT angiography, myocardial perfusion SPECT, PET, and hybrid imaging for diagnosis of ischaemic heart disease
  • AMERICA: Multivascular versus coronary disease treatment alone

Coronary artery disease and stenting is the focus of a dedicated session:

  • NorStent: Long term effects of new generation drug eluting versus contemporary bare metal stents
  • BASKET-SAVAGE: Drug eluting versus bare metal stents in saphenous vein grafts
  • PRAGUE -18: Ticagrelor versus prasugrel in ST-segment elevation myocardial infarction
  • Antithrombotic therapy without stenting for patients with ACS caused by plaque erosion
  • BBK II: Culotte versus T-stenting for treatment of coronary bifurcation lesions

New preventive strategies:

  • ENSURE-AF: Edoxaban for cardioversion of atrial fibrillation
  • ANNEXA-4: Andexanet alfa to reverse Factor Xa inhibitors in acute major bleeding
  • REVERSE II: Identifying venous thromboembolism patients who can discontinue anticoagulants
  • SENTINEL: Cerebral protection in transcatheter aortic valve replacement
  • YEARS: Simplified diagnostic management algorithm for acute pulmonary embolism

Additional late breaking science will be presented with 25 clinical trial updates, 24 registries and 12 basic and translational hot lines presentations.

Original science will also be showcased in the different abstract sessions – the Advances in Science, Rapid Fire Abstracts, and Moderated Posters, Best Posters and traditional posters. Topics of particular interest to the press will be featured in four press conferences on the cardiovascular (CV) risks of modern life, stroke and arrhythmias, heart failure, and preventing sudden death.

Four Press conferences:

The cardiovascular risks of modern life – Saturday 27 August 12:30-13:30

  • Leisure time physical activity reduces risk of CV death and acute CVD events in older adults
  • Healthy School, Happy School: randomised clinical trial designed to stop obesity in children
  • Low socioeconomic status linked with recurrent CVD events in population with stable CHD
  • Personal activity index for promotion of physical activity and prevention of CVD

Stroke and arrhythmia – life or death- Saturday 27 August 15:00-16:00

  • PRAGUE-16: Direct catheter-based thrombectomy for the treatment of acute ischaemic stroke
  • Detecting atrial fibrillation using existing smartphones without add-ons
  • Aspirin monotherapy for stroke prevention in the real world
  • Stroke and mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in AF

Heart failure – challenges and solutions – Sunday 28 August 13:00-14:00

  • Protective effect of nebivolol on anthracycline-induced cardiotoxicity
  • Increasing readmissions to hospital worsen mortality and decrease survival in heart failure patients
  • AGES-Reykjavik Study: heart failure in the elderly and predictions for the future
  • High morbidity and mortality risk in HF and under treatment with evidence based therapies

Preventing sudden death – diet or device – Sunday 28 August 15:00-16:00

  • Risk of motor vehicle accidents in patients with an implantable cardioverter defibrillator
  • Major disparities in implementation of public access defibrillation programmes
  • MOLI-SANI study: Mediterranean diet associated with lower risk of mortality in patients with CVD
  • Circumstances of sudden death in hypertrophic cardiomyopathy

Register now to secure your place at the largest and most influential cardiovascular congress of the year.

###

Media Contact

ESC Press Office
[email protected]
@escardio

http://www.escardio.org

Leave A Reply

Your email address will not be published.